Prostamax (20mg) is a research material supplied in lyophilized form for controlled laboratory and analytical use. It is intended for in vitro research conducted by qualified personnel in appropriately equipped facilities.
Prostamax is marketed as a short peptide bioregulator associated with organ-specific peptide research. Any investigation involving this material should use validated analytical methods, documented controls, and lot-specific characterization data.
The molecular formula, molecular weight, peptide sequence, and CAS number should not be inferred from the product name. Researchers should consult the applicable Certificate of Analysis and technical documentation for the identity and analytical characteristics reported for a specific lot.
Nordsci Peptides provides access to lot-specific analytical documentation through its COA Library. Reported testing methods and results may vary by lot and should be reviewed before beginning an experiment.
FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR HUMAN OR VETERINARY IN VIVO USE. NOT INTENDED FOR DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, OR DIETARY-SUPPLEMENT APPLICATIONS.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Prostamax (20mg) is a research material supplied in lyophilized form for controlled laboratory and analytical use. It is intended exclusively for in vitro research conducted by qualified personnel in appropriately equipped facilities.
Prostamax is marketed as a short peptide bioregulator associated with organ-specific peptide research. Any investigation involving this material should use validated analytical methods, documented controls, and lot-specific characterization data.
The molecular formula, molecular weight, peptide sequence, and CAS number should not be inferred from the product name. Researchers should consult the applicable Certificate of Analysis and technical documentation for the identity and analytical characteristics reported for a specific lot.
Prostamax (20mg) – Research Specifications:
| Product Name | Prostamax |
| Quantity | 20mg per vial |
| Material Type | Research peptide material |
| Molecular Formula | Refer to applicable technical or lot-specific documentation |
| Molecular Weight | Refer to applicable technical or lot-specific documentation |
| CAS Number | Not stated; consult applicable documentation |
| Sequence | Refer to applicable technical or lot-specific documentation |
| Purity / Identity | Lot-specific results are stated on the applicable Certificate of Analysis |
| Appearance | Lyophilized material |
| Storage Conditions | Keep sealed and protected from heat, light, moisture, and contamination; follow lot-specific documentation |
| Testing Documentation | Certificate of Analysis available through the COA Library |
| Research Use Only | For in vitro laboratory research only; not for human or animal consumption |
Prostamax is the commercial designation for a short peptide research material commonly categorized with organ-specific bioregulators. This classification provides research context but does not establish a therapeutic indication, biological outcome, or suitability for human or animal use.
Laboratory investigations involving short peptide materials may examine chemical identity, analytical purity, stability, degradation, and behavior under defined experimental conditions. Any pathway- or tissue-related investigation must be conducted using validated in vitro models and appropriate controls.
Product identity and analytical quality should be evaluated using the documentation supplied for the specific lot. Information from unrelated lots, suppliers, or research materials should not be assumed to apply to this product.
Important Research Notice: Nordsci research materials are accompanied by lot-specific analytical documentation when available. Researchers should review the applicable Certificate of Analysis for reported identity, purity, and testing information.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR HUMAN OR VETERINARY IN VIVO USE. NOT INTENDED FOR DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, OR DIETARY-SUPPLEMENT APPLICATIONS.
Qualified researchers may use Prostamax in controlled in vitro studies designed to examine predefined analytical or signaling variables. The product name and category do not establish an effect on prostate tissue or any other biological system.
In vitro research may evaluate the material under defined cellular assay conditions. Any observed result must be interpreted within the limitations of the selected model and independently validated.
Researchers studying glandular signaling models may include short peptide materials as experimental analytes. Appropriate positive controls, negative controls, assay validation, and reproducibility standards are required.
Laboratory models may examine material behavior under predefined experimental stress conditions. This research context does not indicate a protective, restorative, or therapeutic effect.
Prostamax (20mg) should be handled by qualified personnel in a controlled laboratory environment. Researchers should follow applicable institutional procedures for receiving, labeling, storing, documenting, and disposing of research materials.
Protocol Design Considerations: Experimental plans should define the material identity, lot number, analytical method, acceptance criteria, controls, storage history, and relevant environmental conditions. Results should not be extrapolated to human or animal use.
This page does not provide instructions concerning dosing, administration, injection, consumption, veterinary use, or clinical application.
Note: This information is provided exclusively as a laboratory research reference. Researchers are responsible for determining whether the material and proposed procedures comply with applicable laws, regulations, and institutional requirements.
Lot-specific Certificates of Analysis provide the analytical information reported for Prostamax supplied by Nordsci Peptides. Depending on the testing performed, documentation may identify the analytical method, reported purity, identity findings, lot number, and test date.
Researchers should consult the applicable COA rather than relying on generalized purity or identity statements. Testing methods such as HPLC or mass spectrometry should only be represented as completed when confirmed by the relevant lot-specific report.
Nordsci Peptides supplies Prostamax (20mg) exclusively as a laboratory research material. Laboratories should review the product label, lot-specific Certificate of Analysis, storage information, and institutional requirements before purchasing or using the material.
IMPORTANT: Prostamax (20mg) is not approved for human consumption, animal consumption, therapeutic use, diagnostic use, veterinary use, food use, cosmetic use, or dietary-supplement use. No dosing, administration, or application guidance is provided.
No therapeutic or clinical references are presented because Prostamax is supplied exclusively as a laboratory research material. Researchers should rely on the following resources when evaluating the material:
